US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 15.140
  • +0.120+0.80%
Close Mar 27 16:00 ET
  • 15.140
  • 0.0000.00%
Post 16:05 ET
47.84BMarket Cap34.88P/E (TTM)

About Takeda Pharmaceutical Company

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Company Profile

SymbolTAK
Company NameTakeda Pharmaceutical
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketNYSE
Employees49281
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.com

Company Executives

  • Name
  • Position
  • Salary
  • Akiko Amakawa
  • Corporate Strategy Officer and Chief Executive Officer Chief of Staff
  • --
  • Christophe Weber
  • Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
  • 1.70B
  • Takako Ohyabu
  • Chief Global Corporate Affairs and Sustainability Officer
  • --
  • Mwana Lugogo
  • Chief Ethics and Compliance Officer
  • --
  • Lauren Duprey
  • Chief Human Resources Officer
  • --
  • Milano Furuta
  • Director and Chief Financial Officer
  • --
  • Gabriele Ricci
  • Chief Data and Technology Officer
  • --
  • Elaine Shannon
  • Global Quality Officer
  • --
  • Marcello Agosti
  • Global Business Development Officer
  • --
  • Dr. Thomas Wozniewski, PhD
  • Global Manufacturing and Supply Officer
  • --
  • Teresa Marie Bitetti
  • President, Global Oncology Business Unit
  • --
  • Ramona Sequeira
  • President, Global Portfolio Division
  • --
  • Julie Kim
  • President, U.S. Business Unit and U.S. Country Head
  • --
  • Asuka Miyabashira
  • President, Japan Pharma Business Unit
  • --
  • Masami Iijima
  • Chairman of the Board
  • 43.00M
  • Giles Platford
  • President, Plasma-Derived Therapies Business Unit
  • --
  • Andrew S. Plump, M.D.
  • Director and President, Research and Development
  • 12.00M
  • Miki Tsusaka
  • Independent Director
  • 32.00M
  • Kimberly A. Reed
  • Independent Director
  • 41.00M
  • Emiko Higashi
  • Independent Director
  • 49.00M
  • Yoshiaki Fujimori
  • Independent Director
  • 40.00M
  • Michel Orsinger
  • Independent Director
  • 46.00M
  • Koji Hatsukawa
  • Independent Director
  • 43.00M
  • Jean-Luc Butel
  • Independent Director
  • 38.00M
  • Ian T. Clark
  • Independent Director
  • 44.00M
  • Dr. Steven Gillis, Pd.D
  • Independent Director
  • 44.00M
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 39.00M
  • Yoshihiro Nakagawa
  • Global General Counsel
  • --

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Alibaba
BABA
135.630
Apple
AAPL
223.850
Intel
INTC
23.620
4
Netflix
NFLX
976.720
5
Tesla
TSLA
273.130
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.